Static Chart LifeTech Scientific Corporation

Equities

Delayed Hong Kong S.E. Other stock markets 08:22:24 28/05/2024 BST			5-day change	1st Jan Change
1.68 ^HKD	-1.18%		-7.14%	-28.09%

05-16	LifeTech Scientific Completes Follow-up of Phase 2 Clinical Study of IBS Coronary Scaffold	MT
05-15	LifeTech Scientific Corporation Announces One-Year Follow-Up Results of Phase II Clinical Study of IBS Sirolimus-Eluting Iron Bioresorbable Coronary Scaffold System	CI

Duration

Period